Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

AMANTADINE 50 MG/5 ML SOLUTION

Amantadine
$0.0502per ML

Strength

50 mg/5mL

Manufacturer

Xttrium Laboratories, Inc.

NDC

00116401016

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

AMANTADINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075060

On Market Since

11/5/2024

Pharmacological Classes

Influenza A M2 Protein Inhibitor
M2 Protein Inhibitors

Price History

1W

0.0%

1M

-1.3%

3M

-0.4%

6M

+3.7%

1Y

-13.3%

3Y

N/A

5Y

N/A

All

-14.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

AMANTADINE 50 MG/5 ML SOLUTION
Generic
00121064616•PAI Holdings LLC
$0.0502
per ML
AMANTADINE 50 MG/5 ML SOLUTION
Generic
39328053016•Patrin Pharma Inc.
$0.0502
per ML
AMANTADINE 50 MG/5 ML SOLUTION
Generic
62135001047•Chartwell RX LLC
$0.0502
per ML
AMANTADINE 100 MG CAPSULE
Generic
00832101500•Upsher-Smith Laboratories LLC
$0.1555
per EA
AMANTADINE 100 MG CAPSULE
Generic
00832101550•Upsher-Smith Laboratories LLC
$0.1555
per EA
AMANTADINE 100 MG CAPSULE
Generic
00904704206•Major Pharmaceuticals
$0.1555
per EA
AMANTADINE 100 MG CAPSULE
Generic
00904704240•Major Pharmaceuticals
$0.1555
per EA
AMANTADINE 100 MG CAPSULE
Generic
00904704259•Major Pharmaceuticals
$0.1555
per EA
AMANTADINE 100 MG CAPSULE
Generic
00904704261•Major Pharmaceuticals
$0.1555
per EA
AMANTADINE 100 MG CAPSULE
Generic
16571083401•Rising Pharma Holdings Inc.
$0.1555
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy